港股異動 | 港股通"新秀"受內資青睞,天立教育飆漲20%,信達生物漲超12%
uSMART友信智投9月7日消息,港股通股票名單的調整今日起生效,"新秀們"週一早盤表現亮眼,截至9:57分,天立教育飆漲21%,信達生物大漲12.45%,九毛九飆漲10%,永升生活服務、海吉亞醫療均漲超7%,寶龍商業漲超4%。
9月4日,上交所發佈《關於滬港通下港股通股票名單調整及下一次定期調整時間的通知》顯示,鷹君(0041.HK)、金地商置(0535.HK)、微創醫療(0853.HK)、香港寬頻(1310.HK)、新東方在線(1797.HK)、信達生物(1801.HK)、中海物業(2669.HK)、百濟神州(6160.HK)、宇華教育(6169.HK)、康基醫療(9997.HK)等10只個股獲納入滬港通下的港股通股票名單,自9月7日起生效。
下圖爲滬港通調整名單:
同日,深交所發佈的《關於深港通下的港股通股票名單調整的公告》顯示,天立教育、永升生活服務、寶龍商業、百濟神州等24只個股獲納入深港通下的港股通股票名單,自9月7日起生效。
下圖爲深港通調整名單:
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.